New IV drug shows promise for painful blistering skin disease
NCT ID NCT03135548
Summary
This study tested whether a new intravenous drug called BI 655130 could safely reduce symptoms of palmoplantar pustulosis (PPP), a painful condition causing blisters and scaling on the palms and soles. In this 16-week trial, 59 adults with PPP received either the drug or a placebo to compare effectiveness. The main goal was to see if the drug could significantly improve skin symptoms and was safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus University Hospital, Skejby
Aarhus, 8200, Denmark
-
Bispebjerg og Frederiksberg Hospital
København NV, 2400, Denmark
-
Charité - Universitätsmedizin Berlin
Berlin, 10117, Germany
-
Dr. Irina Turchin PC Inc.
Fredericton, New Brunswick, E3B 1G9, Canada
-
Gentofte Hospital
Hellerup, 2900, Denmark
-
Hospital Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Santa Creu i Sant Pau
Barcelona, 08026, Spain
-
Hospital Universitario Infanta Leonor
Madrid, 28031, Spain
-
Innovaderm Research Inc.
Montreal, Quebec, H2K 4L5, Canada
-
Karolinska Univ. sjukhuset
Stockholm, 171 76, Sweden
-
Ospedale San Giovanni di Dio
Cagliari, 09124, Italy
-
Pol. Universitario Tor Vergata
Roma, 00133, Italy
-
Sahlgrenska US, Göteborg
Gothenburg, 413 45, Sweden
-
TFS Trial Form Support GmbH
Hamburg, 20537, Germany
-
Universitätsklinikum Frankfurt
Frankfurt am Main, 60596, Germany
-
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitätsklinikum Schleswig-Holstein, Campus Kiel
Kiel, 24105, Germany
-
York Dermatology Clinic and Research Centre
Richmond Hill, Ontario, L4C 9M7, Canada
Conditions
Explore the condition pages connected to this study.